enGene Holdings Inc.

enGene Holdings Inc.verified

ENGN

Price:

$1.62

Market Cap:

$82.94M

Operating through its subsidiary, enGene, Inc., enGene Holdings Inc. functions as a clinical-stage biotechnology firm. Its core mission involves pioneering genetic pharmaceuticals, achieved by administering therapeutic agents directly to mucosal tissues and other bodily organs. A key asset in its pipeline is EG-70, also known as detalimogene voraplasmid. This innovative non-viral immunotherapy is being developed to treat non-muscle invasive bladder cancer in patients diagnosed with carcinoma-in-situ (Cis) who have shown no improvement after Bacillus Calmette-Guérin therapy. The company was established in 2023 and is headquartered in Saint-Laurent, Canada.

Industry

Biotechnology

IPO Date

2022-02-01

Stock Exchange

NASDAQ

Ticker

ENGN

The PE Ratio as of June 2026 (TTM) for enGene Holdings Inc. (ENGN) is -0.72

According to enGene Holdings Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.72. This represents a change of -75.05% compared to the average of -2.89 of the last 4 quarters.

enGene Holdings Inc. (ENGN) Historical PE Ratio (quarterly & annually)

How has ENGN PE Ratio performed in the past?

The mean historical PE Ratio of enGene Holdings Inc. over the last ten years is -10.41. The current -0.72 PE Ratio has changed 591.97% with respect to the historical average. Over the past ten years (40 quarters), ENGN's PE Ratio was at its highest in in the July 2025 quarter at -1.67. The PE Ratio was at its lowest in in the December 2021 quarter at -367.74.

Quarterly (TTM)
Annual

Average

-10.41

Median

-10.05

Minimum

-20.99

Maximum

-3.14

enGene Holdings Inc. (ENGN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of enGene Holdings Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 51.93%

Maximum Annual PE Ratio = -3.14

Minimum Annual Increase = -63.53%

Minimum Annual PE Ratio = -20.99

Quarterly (TTM)
Annual
YearPE RatioChange
2025-3.14-56.14%
2024-7.1651.93%
2023-4.72-63.53%
2022-12.93-4.17%
2021-13.49-35.72%

enGene Holdings Inc. (ENGN) Average PE Ratio

How has ENGN PE Ratio performed in the past?

The current PE Ratio of enGene Holdings Inc. (ENGN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-5.01

5-year avg

-8.29

10-year avg

-10.41

enGene Holdings Inc. (ENGN) PE Ratio vs. Peers

How is ENGN’s PE Ratio compared to its peers?

enGene Holdings Inc.’s PE Ratio is greater than Amarin Corporation plc (-9.43), greater than Altimmune, Inc. (-3.57), greater than Korro Bio, Inc. (-1.19), greater than DBV Technologies S.A. (-8.91), greater than Larimar Therapeutics, Inc. (-1.78), greater than Cellectis S.A. (-4.79), greater than Annexon, Inc. (-4.66), greater than Alto Neuroscience, Inc. (-9.50), greater than AC Immune S.A. (-2.74), greater than Silence Therapeutics plc (-3.71),

Build a custom stock screener for enGene Holdings Inc. (ENGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like enGene Holdings Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

enGene Holdings Inc. (ENGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like enGene Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is enGene Holdings Inc.'s PE Ratio?

How is the PE Ratio calculated for enGene Holdings Inc. (ENGN)?

What is the highest PE Ratio for enGene Holdings Inc. (ENGN)?

What is the 3-year average PE Ratio for enGene Holdings Inc. (ENGN)?

What is the 5-year average PE Ratio for enGene Holdings Inc. (ENGN)?

How does the current PE Ratio for enGene Holdings Inc. (ENGN) compare to its historical average?